{"DataElement":{"publicId":"3253675","version":"1","preferredName":"Dysplasia Therapeutic Procedure Percentage Anal Neoplasm Performed Type","preferredDefinition":"the percentage of an area of anal dysplasia that was involved and/or treated.","longName":"3253660v1.0:3253671v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3253660","version":"1","preferredName":"Dysplasia Therapeutic Procedure Percentage Anal Neoplasm Performed","preferredDefinition":"information relating to a therapeutic procedure (an action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process) for dysplasia (the presence of cells that look abnormal under a microscope but are not cancer) performed (carried out) and the percentage (a fraction or ratio with 100 understood as the denominator) of an anal neoplasm (a benign or malignant neoplasm involving the anus).","longName":"2459191v1.0:3253658v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2459191","version":"1","preferredName":"Dysplasia","preferredDefinition":"A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns.  The cellular changes include nuclear and cytoplasmic abnormalities.  Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer. -- 2004","longName":"C4086","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dysplasia","conceptCode":"C4086","definition":"A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F0AEBD7-944A-60D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-15","modifiedBy":"ONEDATA","dateModified":"2006-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3253658","version":"1","preferredName":"Therapeutic Procedure Percentage Anal Neoplasm Performed","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:Percentage; a fraction or ratio with 100 understood as the denominator.:A benign or malignant neoplasm involving the anus.:Performed; carried out.","longName":"C49236:C25613:C2877:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Anal Neoplasm","conceptCode":"C2877","definition":"A benign or malignant neoplasm that affects the anal canal or anal margin.  Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma.  Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A82050EA-C3C5-10CA-E040-BB89AD432E6F","latestVersionIndicator":"Yes","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"ONEDATA","dateModified":"2011-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A82050EA-C3D6-10CA-E040-BB89AD432E6F","latestVersionIndicator":"Yes","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3253671","version":"1","preferredName":"Dysplasia Therapeutic Procedure Percentage Anal Neoplasm Type","preferredDefinition":"the percentage of an area of anal dysplasia that was involved and/or treated.","longName":"3253671v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"> 50%","valueDescription":"> 50%","ValueMeaning":{"publicId":"3253672","version":"1","preferredName":"> 50%","longName":"3253672","preferredDefinition":"> 50%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A82106D9-814E-4C27-E040-BB89AD435EAD","latestVersionIndicator":"Yes","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A82106D9-8167-4C27-E040-BB89AD435EAD","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"ONEDATA","dateModified":"2011-07-15","deletedIndicator":"No"},{"value":"26-50%","valueDescription":"26-50%","ValueMeaning":{"publicId":"3250650","version":"1","preferredName":"26-50%","longName":"3250650","preferredDefinition":"26-50%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F45B62-130B-1CD3-E040-BB89AD436917","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"JARVISK","dateCreated":"2011-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A82106D9-8171-4C27-E040-BB89AD435EAD","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"ONEDATA","dateModified":"2011-07-15","deletedIndicator":"No"},{"value":"6-25%","valueDescription":"6-25%","ValueMeaning":{"publicId":"3253673","version":"1","preferredName":"6-25%","longName":"3253673","preferredDefinition":"6-25%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A82106D9-817C-4C27-E040-BB89AD435EAD","latestVersionIndicator":"Yes","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A82106D9-8195-4C27-E040-BB89AD435EAD","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"ONEDATA","dateModified":"2011-07-15","deletedIndicator":"No"},{"value":"<= 5%","valueDescription":"<= 5%","ValueMeaning":{"publicId":"3253674","version":"1","preferredName":"<= 5%","longName":"3253674","preferredDefinition":"<= 5%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A82106D9-819F-4C27-E040-BB89AD435EAD","latestVersionIndicator":"Yes","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A82106D9-81B8-4C27-E040-BB89AD435EAD","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"ONEDATA","dateModified":"2011-07-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A82106D9-8138-4C27-E040-BB89AD435EAD","latestVersionIndicator":"Yes","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"SHIDED","dateModified":"2011-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Percentage of perianal or int","type":"Preferred Question Text","description":"Percentage of perianal or intraanal area treated","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Estimate the percentage of the perianal or intraanal area that was treated","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"What percentage of the area is covered by lesions","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A82106D9-81C2-4C27-E040-BB89AD435EAD","latestVersionIndicator":"Yes","beginDate":"2011-07-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-07-15","modifiedBy":"ALAIS","dateModified":"2012-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}